utilizing immunomodulatory treatments to navigate a challenging case of pediatric COVID-19.

Published Date: 22 Oct 2023

According to a poster session at the 2023 American Academy of Pediatrics National Conference and Exhibition, eculizumab and anakinra should be taken into account in critically ill patients with serious infections who need immunomodulating treatments for life-threatening dysregulation.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Psychedelic Therapy Tied to Reduced Depression, Anxiety.

2.

New drug resistance mechanism in melanoma leptomeningeal disease revealed by study.

3.

Research finds stark disparities in treatment and survival time for people with pancreatic cancer

4.

Tumor characteristics found to differ for melanomas in children, teens and young adults

5.

Relationship-building key to addressing oncologist shortages in rural care


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot